1. Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. Issue 12 (4th September 2021) Authors: Forsberg, Peter A.; Rossi, Adriana C.; Boyer, Angelique; Pearse, Roger N.; Pekle, Karen A.; Jayabalan, David; Lakritz, Stephanie; Flicker, Kari; Ribadeneyra, Drew; Liotta, Brielle; Ely, Scott; Boussi, Leora; Allan, John N.; Coleman, Morton; Niesvizky, Ruben; Mark, Tomer M. Journal: American journal of hematology Issue: Volume 96:Issue 12(2021) Page Start: 1554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Issue 28 (1st October 2021) Authors: Moskowitz, Alison J.; Shah, Gunjan; Schöder, Heiko; Ganesan, Nivetha; Drill, Esther; Hancock, Helen; Davey, Theresa; Perez, Leslie; Ryu, Sunyoung; Sohail, Samia; Santarosa, Alayna; Galasso, Natasha; Neuman, Rachel; Liotta, Brielle; Blouin, William; Kumar, Anita; Lahoud, Oscar; Batlevi, Connie L.;... Journal: Journal of clinical oncology Issue: Volume 39:Issue 28(2021) Page Start: 3109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗